Combination adjuvants: clinical value and mechanisms of action.

Authors

Natacha Madelon, Arnaud M Didierlaurent

Published in

Current opinion in virology. Volume 76. Pages 101564. Jun 19, 2026. Epub Jun 19, 2026.

Abstract

Combination adjuvants enhance vaccine immunogenicity by integrating multiple immunostimulatory signals that shape both innate and adaptive immune responses. In this review, we summarize the clinical evidence supporting the added value of combination adjuvants, including aluminum-Toll-like receptor ligand formulations, oil-in-water emulsions containing immunostimulatory molecules, and saponin-based systems. We further discuss how the most recent mechanistic studies have shown that combination adjuvants act through additive or synergistic effects, engaging distinct molecular and cellular pathways to shape innate immune activation. Moreover, we propose that mRNA vaccines represent a new class of functional combination adjuvants, integrating both mRNA sensing and lipid nanoparticle-driven inflammation. Together, the current evidence supports the value of combination adjuvants in optimizing vaccine responses and underscores the need to continuously understand their mode of action to enable rational adjuvant design.

PMID:
42320106
Bibliographic data and abstract were imported from PubMed on 20 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.